Literature DB >> 7678307

Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T lymphocytes.

A L Rothman1, I Kurane, C J Lai, M Bray, B Falgout, R Men, F A Ennis.   

Abstract

The identification of the protein targets for dengue virus-specific T lymphocytes may be useful for planning the development of subunit vaccines against dengue. We studied the recognition by murine dengue virus-specific major histocompatibility complex class I-restricted, CD8+ cytotoxic T lymphocytes (CTL) of dengue virus proteins using recombinant vaccinia viruses containing segments of the dengue virus genome. CTL from H-2k mice recognized a single serotype-cross-reactive epitope on the nonstructural (NS) protein NS3. CTL from H-2b mice recognized a serotype-cross-reactive epitope that was localized to NS4a or NS4b. CTL from H-2d mice recognized at least three epitopes: a serotype-specific epitope on one of the structural proteins, a serotype-cross-reactive epitope on NS3, and a serotype-cross-reactive epitope on NS1 or NS2a. Our findings demonstrate the limited recognition of dengue virus proteins by CTL from three inbred mouse strains and the predominance of CTL epitopes on dengue virus nonstructural proteins, particularly NS3. Since human dengue virus-specific CTL show similar patterns of recognition, these findings suggest that nonstructural proteins should be considered in designing vaccines against dengue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678307      PMCID: PMC237433     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  The nucleotide sequence of dengue type 4 virus: analysis of genes coding for nonstructural proteins.

Authors:  E Mackow; Y Makino; B T Zhao; Y M Zhang; L Markoff; A Buckler-White; M Guiler; R Chanock; C J Lai
Journal:  Virology       Date:  1987-08       Impact factor: 3.616

2.  Cloning full-length dengue type 4 viral DNA sequences: analysis of genes coding for structural proteins.

Authors:  B Zhao; E Mackow; A Buckler-White; L Markoff; R M Chanock; C J Lai; Y Makino
Journal:  Virology       Date:  1986-11       Impact factor: 3.616

3.  Expression of H-2Dd and H-2Ld mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer.

Authors:  D H Margulies; G A Evans; K Ozato; R D Camerini-Otero; K Tanaka; E Appella; J G Seidman
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

4.  Cell-mediated immunity in flavivirus infections. I. Induction of cytotoxic T lymphocytes in mice by an attenuated virus from the tick-borne encephalitis complex and its group-reactive character.

Authors:  E Gajdosová; C Oravec; V Mayer
Journal:  Acta Virol       Date:  1981-01       Impact factor: 1.162

5.  Broad cross-reactivity with marked fine specificity in the cytotoxic T cell response to flaviviruses.

Authors:  A B Hill; A Müllbacher; C Parrish; G Coia; E G Westaway; R V Blanden
Journal:  J Gen Virol       Date:  1992-05       Impact factor: 3.891

6.  Anti-influenza virus cytotoxic T lymphocytes recognize the three viral polymerases and a nonstructural protein: responsiveness to individual viral antigens is major histocompatibility complex controlled.

Authors:  J R Bennink; J W Yewdell; G L Smith; B Moss
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

7.  Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak.

Authors:  N Sangkawibha; S Rojanasuphot; S Ahandrik; S Viriyapongse; S Jatanasen; V Salitul; B Phanthumachinda; S B Halstead
Journal:  Am J Epidemiol       Date:  1984-11       Impact factor: 4.897

8.  Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.

Authors:  S Chakrabarti; K Brechling; B Moss
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

9.  Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity.

Authors:  I Kurane; D Hebblewaite; W E Brandt; F A Ennis
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

10.  Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered.

Authors:  S B Halstead; S Nimmannitya; S N Cohen
Journal:  Yale J Biol Med       Date:  1970-04
View more
  16 in total

1.  Genetic vaccination of mice with plasmids encoding the NS1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus.

Authors:  A V Timofeev; V M Butenko; J R Stephenson
Journal:  Virus Genes       Date:  2004-01       Impact factor: 2.332

Review 2.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

3.  Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein.

Authors:  T R Kreil; E Maier; S Fraiss; M M Eibl
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

4.  Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell response.

Authors:  James S Testa; Vivekananda Shetty; Gomathinayagam Sinnathamby; Zacharie Nickens; Julie Hafner; Shivali Kamal; Xianchao Zhang; Marti Jett; Ramila Philip
Journal:  J Infect Dis       Date:  2012-01-13       Impact factor: 5.226

5.  Recognition of envelope protein by dengue virus serotype-specific human CD4+ CD8- cytotoxic T-cell clones.

Authors:  P G Livingston; I Kurane; C J Lai; M Bray; F A Ennis
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

6.  A novel immunization approach for dengue infection based on conserved T cell epitopes formulated in calcium phosphate nanoparticles.

Authors:  Xiaofang Huang; Aykan Karabudak; Joseph D Comber; Mohan Philip; Tulin Morcol; Ramila Philip
Journal:  Hum Vaccin Immunother       Date:  2017-09-21       Impact factor: 3.452

7.  Differential in vivo clearance and response to secondary heterologous infections by H2(b)-restricted dengue virus-specific CD8+ T cells.

Authors:  Coreen M Beaumier; Smita Jaiswal; Kim Y West; Heather Friberg; Anuja Mathew; Alan L Rothman
Journal:  Viral Immunol       Date:  2010-10       Impact factor: 2.257

8.  Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.

Authors:  A Mathew; I Kurane; A L Rothman; L L Zeng; M A Brinton; F A Ennis
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

9.  Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.

Authors:  K Kurokohchi; T Akatsuka; C D Pendleton; A Takamizawa; M Nishioka; M Battegay; S M Feinstone; J A Berzofsky
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones.

Authors:  S J Gagnon; W Zeng; I Kurane; F A Ennis
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.